Nino Balanchivadze, MD, FACP

Nina Balanchivadze, MD, FACP, discusses how inclusive research begins at the community level by addressing barriers to trial participation.

Nino Balanchivadze, MD, FACP, discusses the rationale for evaluating toxicity based on race in the KEYNOTE-189 study.

Nino Balanchivadze, MD, FACP, discusses the results of an analysis investigating renal toxicity in patients with nonsquamous non–small cell lung cancer in relation to the race of patients.